NCT04562168

Brief Summary

Background: Dermatological conditions are a relevant health problem. Machine learning models are increasingly being applied to dermatology as a diagnostic decision support tool using image analysis, specially for skin cancer detection and classification. Objective: The objective of this study is to perform a prospective validation of an image analysis ML model, which is capable of screening 44 different skin disease types, comparing its diagnostic capacity with that of General Practitioners (GPs) and dermatologists. Methods: In this prospective study 100 consecutive patients who visit a participant GP with a skin problem in central Catalonia will be recruited, data collection is planned to last 7 months. Skin diseases anonymized pictures will be taken and introduced in the ML model interface, which will return top 5 accuracy diagnosis. The same image will be also sent as a teledermatology consultation, following the current workflow. GP, ML model and dermatologist/s assessments will be compared to calculate the precision, sensitivity, specificity and accuracy of the ML model.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2020

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 24, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

January 15, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 5, 2022

Status Verified

March 1, 2022

Enrollment Period

12 months

First QC Date

August 28, 2020

Last Update Submit

May 4, 2022

Conditions

Keywords

Machine LearningArtificial IntelligenceData accuracyComputed Assisted DiagnosisNeural Network Computer

Outcome Measures

Primary Outcomes (4)

  • Sensitivity of the ML model

    True positive rate of the ML model

    1 year

  • Specificity of the ML model

    True negative rate of the ML model

    1 year

  • Accuracy of the ML model

    Ratio of number of correct predictions to the total number of input samples

    1 year

  • Area under the receiver operating characteristic curve of the ML model

    Diagnostic ability of the ML model

    1 year

Secondary Outcomes (1)

  • Rate of the eligible participants who agree to participate in the study

    1 year

Study Arms (1)

Diagnostic Test: ML model

EXPERIMENTAL

The diagnostic capacity of the ML model will be compared with that of the general practitioners and with dermatologist.

Diagnostic Test: Autoderm® dermatology search engine (ML model) testing

Interventions

GP using a smartphone camera will take an image of the skin problem and will use the Autoderm ML interface to upload the anonymized image. The obtained predicted diagnosis will be recorded in case report form.

Diagnostic Test: ML model

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who have cutaneous disease reason-for-visit.
  • Patients who provide written informed consent.
  • Patients who are 18 years of age or older.

You may not qualify if:

  • Patients with advanced dementia.
  • Patients with a cutaneous lesion which can't be photographed with a smartphone and images with poor quality.
  • Patients who have conditions associated with risk of poor protocol compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CAP Navàs

Navàs, Barcelona, 08670, Spain

Location

Related Publications (16)

  • Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV. The burden of skin disease in the United States. J Am Acad Dermatol. 2017 May;76(5):958-972.e2. doi: 10.1016/j.jaad.2016.12.043. Epub 2017 Mar 1.

  • Schofield JK, Fleming D, Grindlay D, Williams H. Skin conditions are the commonest new reason people present to general practitioners in England and Wales. Br J Dermatol. 2011 Nov;165(5):1044-50. doi: 10.1111/j.1365-2133.2011.10464.x. Epub 2011 Sep 22.

  • Dokotor.se [Internet]. Survey Telemedicine statistics Dokotor.se, the % of queries that are dermatology related 2019 [cited 2019]

    RESULT
  • Activitat assistencial de la xarxa sanitària de Catalunya, any 2012: registre del conjunt mínim bàsic de dades (CMBD). Barcelona: Departament de Salut. 2013.

    RESULT
  • Lowell BA, Froelich CW, Federman DG, Kirsner RS. Dermatology in primary care: Prevalence and patient disposition. J Am Acad Dermatol. 2001 Aug;45(2):250-5. doi: 10.1067/mjd.2001.114598.

  • Porta N, San Juan J, Grasa MP, Simal E, Ara M, Querol MA. [Diagnostic agreement between primary care physicians and dermatologists in the health area of a referral hospital]. Actas Dermosifiliogr. 2008 Apr;99(3):207-12. Spanish.

  • Lopez Segui F, Franch Parella J, Girones Garcia X, Mendioroz Pena J, Garcia Cuyas F, Adroher Mas C, Garcia-Altes A, Vidal-Alaball J. A Cost-Minimization Analysis of a Medical Record-based, Store and Forward and Provider-to-provider Telemedicine Compared to Usual Care in Catalonia: More Agile and Efficient, Especially for Users. Int J Environ Res Public Health. 2020 Mar 18;17(6):2008. doi: 10.3390/ijerph17062008.

  • Borve A, Dahlen Gyllencreutz J, Terstappen K, Johansson Backman E, Aldenbratt A, Danielsson M, Gillstedt M, Sandberg C, Paoli J. Smartphone teledermoscopy referrals: a novel process for improved triage of skin cancer patients. Acta Derm Venereol. 2015 Feb;95(2):186-90. doi: 10.2340/00015555-1906.

  • Ferrer RT, Bezares AP, Manes AL, Mas AV, Gutierrez IT, Llado CN, Estaras GM. [Diagnostic reliability of an asynchronous teledermatology consultation]. Aten Primaria. 2009 Oct;41(10):552-7. doi: 10.1016/j.aprim.2008.11.012. Epub 2009 Jun 5. Spanish.

  • Gomolin A, Netchiporouk E, Gniadecki R, Litvinov IV. Artificial Intelligence Applications in Dermatology: Where Do We Stand? Front Med (Lausanne). 2020 Mar 31;7:100. doi: 10.3389/fmed.2020.00100. eCollection 2020.

  • Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017 Feb 2;542(7639):115-118. doi: 10.1038/nature21056. Epub 2017 Jan 25.

  • Liu Y, Jain A, Eng C, Way DH, Lee K, Bui P, Kanada K, de Oliveira Marinho G, Gallegos J, Gabriele S, Gupta V, Singh N, Natarajan V, Hofmann-Wellenhof R, Corrado GS, Peng LH, Webster DR, Ai D, Huang SJ, Liu Y, Dunn RC, Coz D. A deep learning system for differential diagnosis of skin diseases. Nat Med. 2020 Jun;26(6):900-908. doi: 10.1038/s41591-020-0842-3. Epub 2020 May 18.

  • Kamulegeya L, Bwanika J, Okello M, Rusoke D, Nassiwa F, Lubega W, Musinguzi D, Borve A. Using artificial intelligence on dermatology conditions in Uganda: a case for diversity in training data sets for machine learning. Afr Health Sci. 2023 Jun;23(2):753-763. doi: 10.4314/ahs.v23i2.86.

  • Evaluation of the diagnostic accuracy of an online artificial intelligence app for skin disease diagnosis. Alexander Larson, Degree Project in Medicine, Sahlgrenska University Hospital Department of Dermatology and Venereology, Gothenburg, Sweden 2018.

    RESULT
  • Brinker TJ, Hekler A, Enk AH, Klode J, Hauschild A, Berking C, Schilling B, Haferkamp S, Schadendorf D, Holland-Letz T, Utikal JS, von Kalle C; Collaborators. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task. Eur J Cancer. 2019 May;113:47-54. doi: 10.1016/j.ejca.2019.04.001. Epub 2019 Apr 10.

  • Haenssle HA, Fink C, Schneiderbauer R, Toberer F, Buhl T, Blum A, Kalloo A, Hassen ABH, Thomas L, Enk A, Uhlmann L; Reader study level-I and level-II Groups; Alt C, Arenbergerova M, Bakos R, Baltzer A, Bertlich I, Blum A, Bokor-Billmann T, Bowling J, Braghiroli N, Braun R, Buder-Bakhaya K, Buhl T, Cabo H, Cabrijan L, Cevic N, Classen A, Deltgen D, Fink C, Georgieva I, Hakim-Meibodi LE, Hanner S, Hartmann F, Hartmann J, Haus G, Hoxha E, Karls R, Koga H, Kreusch J, Lallas A, Majenka P, Marghoob A, Massone C, Mekokishvili L, Mestel D, Meyer V, Neuberger A, Nielsen K, Oliviero M, Pampena R, Paoli J, Pawlik E, Rao B, Rendon A, Russo T, Sadek A, Samhaber K, Schneiderbauer R, Schweizer A, Toberer F, Trennheuser L, Vlahova L, Wald A, Winkler J, Wolbing P, Zalaudek I. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol. 2018 Aug 1;29(8):1836-1842. doi: 10.1093/annonc/mdy166.

MeSH Terms

Conditions

Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2020

First Posted

September 24, 2020

Study Start

January 15, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

May 5, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

The protocol will be published.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
End of the study
Access Criteria
Information will be published in international scientific journals

Locations